NECA High-Level
Strategic Plan 2025 - 2027

Our Purpose

To raise awareness and understanding of neuroendocrine cancer (NETs), both within the medical profession and the wider Australian public, and provide support to our NET community.

Our Mission

To assist and support patients and carers; lobby for new, appropriate treatments and investigations; raise awareness and knowledge of neuroendocrine cancers within the medical community and general public and encourage and support neuroendocrine cancer Research.

Our Vision

Our vision continues to be the
champions of earlier diagnosis
and a cure for neuroendocrine
cancer.

Our Values

Group 319

Nurture

Cultivate growth and compassion through patient care and support.

Frame 104

Empower

Ignite confidence to create positive change.

Group 321

Care

Demonstrate genuine concern and empathy for the well-being of others.

Group 322

Accountable

Take responsibility for our actions with integrity and transparency.

Our Pillars

We will achieve the strategic priorities through activities that fall within our pillars.

Support

Education

Research

Awareness

Advocacy

Strategic Priorities

These priorities will set the goals we are aiming to achieve in the next 3 years (2025 – 2027).

2025 Goals

2026 Goals

2027 Goals

Support
Enhance NET patient support
2025 Goals
  • Secure additional funding to provide ongoing regional &
    rural access to services and
    support
  • Obtain additional nurses
    providing telehealth and
    referral pathways as per ACNNP – Specialist Support Services
2026 Goals
  • Continue to monitor effects of services and introduce additional services to meet our patients needs
  • Continue to increase staff within the allocated budget (Specialist Support Services Grant)
  • Lobby for ongoing funding past 2027 for Specialist Support Services
2027 Goals
  • Secure national coverage of NET specialist nurses across all states and territories, including regional and rural areas
  • Strengthen integrated care pathways between NECA services, hospitals and primary care
  • Advocate for long-term, sustainable funding for Specialist Support Services beyond 2027
    Improve accessibility of support services for culturally and linguistically diverse (CALD) communities and Aboriginal and Torres Strait Islander peoples
  • Develop culturally appropriate models of care to ensure equitable access to support services
Education
Increase education
2025 Goals
  • Develop medical & nursing
    materials and curriculums
  • Expand presence at relevant
    medical, industry and
    consumer conferences as
    invited speakers
  • Develop PRRT education module for HCPs
  • Develop Dietitian Education
    Modules for implementation
    nationally and internationally
2026 Goals
  • Develop and expand educational resources for multidisciplinary HCPs
  • Garner support for inclusion of educational materials in
    relevant medical/nurse
    curriculums
  • Maintain currency of resources – review regularly and develop additional educational resources
2027 Goals
  • Deliver structured national and international education programs for healthcare professionals across disciplines

  • Ensure ongoing review and development of patient and HCP resources to reflect best practice

  • Translate and adapt patient education materials to improve accessibility for culturally and linguistically diverse (CALD) communities

  • Partner with community organisations to deliver culturally appropriate education for CALD and Aboriginal and Torres Strait Islander audiences

Awareness
Increase awareness and visibility
2025 Goals
  • Undertake ongoing awareness campaign
  • Host dedicated annual event – nationally and then state events in collaboration
  • Increased media exposure by expanding journalist outreach
  • Development of media kit for MPs & third parties
2026 Goals
  • Increased attendance over previous year s dedicated annual NETs event
  • Expand use of media kit for third parties to use 
  • Enhance media engagement by 15% increase on previous
    year’s media presence
2027 Goals
  • Deliver coordinated national awareness campaigns aligned to key policy and funding priorities
  • Strengthen media engagement to increase visibility of neuroendocrine cancer at a national level
  • Expand use of patient storytelling to highlight system gaps and drive engagement
  • Equip stakeholders, MPs and partners with tools to amplify awareness messaging
  • Deliver targeted awareness initiatives to reach priority and underrepresented communities, including culturally and linguistically diverse (CALD) communities, Aboriginal and Torres Strait Islander peoples, regional and rural populations, older Australians and people living with mental illness\
  • Increase reach of campaigns through culturally relevant channels and partnerships
Research
Foster advancements and innovation
2025 Goals
  • Secure funding for Genetic/ Genomic Study and commencement of research
  • Increased data entry to PLANET Registry
  • Monitor government funding for NET Research and clinical trials
  • Explore partners in non-government research 
2026 Goals
  • Sustainability of PLANET
  • Enhance consumer education in research to increase participation in research, study and trial development
  • Lobby government for equitable funding including NHMRC & MRFF
2027 Goals
  • Strengthen national data capability through expansion and utilisation of the PLANET Registry
  • Increase collaboration and inclusion with research, clinical and industry partners nationally and internationally
  • Advocate for increased and equitable government investment in NET research
  • Work with industry and government to strengthen Australia’s position as a destination for global clinical trials, improving patient access to emerging therapies
  • Promote inclusive research practices to ensure representation of diverse patient populations and rare/less common conditions
Advocacy
Equity of access to treatments (PBS)
Equity of access to diagnostic investigations (MBS)
  • Clinical Trial funding (dedicated stream for Rare & Less Common Cancers)
  • Continued implementation of
    the National Action Plan
2025 Goals
2026 Goals
  • Continued implementation of the National Action Plan
  • Recognition—secure ongoing funding from Government by lobbying for support services and resources
  • Garner third party support to lobby on NECAs behalf for significant allocation of funding of NETs through major MRFF grant or Federal Budget item
2027 Goals
  • Drive policy reform to improve timeliness of access to treatments, including HTA processes
  • Maintain accountability on implementation of Senate Inquiry recommendations
  • Secure national and state-based investment in NET specialist nursing and support services
  • Strengthen coordinated engagement with government, policymakers and key stakeholders
  • Expand advocacy influence through partnerships and third-party engagement
  • Position NECA as a leading patient voice in policy, research and system reform
  • Advocate for equitable access to diagnosis, treatment and care across all populations, addressing disparities in underserved communities
Financial Sustainability
Increase funding
2025 Goals
  • Government funding—State & Federal for awareness & nursing program
  • Clinical Trials – partnerships & applications for grants NHMRS / MRFF
  • Corporate Partners
  • Prebudget Submission
  • Organisation Events for fundraising state and national
2026 Goals
  • Philanthropic promotion
  • Bequests – Gift in wills
  • Organisation Events for fundraising state and national
  • Corporate Partners
  • Prebudget Submission
2027 Goals
  • Secure sustained and diversified government funding across federal and state levels
  • Expand partnerships across corporate, philanthropic and research sectors
  • Grow revenue through national and state-based fundraising initiatives
  • Strengthen alignment between funding opportunities and strategic priorities
  • Increase investment to support expanded reach and engagement with all NET community

Tax Appeal

Screenshot 2026-05-20 at 2.12.07 PM

Help 31,000+ neuroendocrine cancer patients get the specialised care they deserve.

Every dollar raised is fully tax deductible and helps fund much needed advocacy efforts and patient support.

National Action Plan: Key Action 2 & 8

NECA’s National Action Plan, plans to establish and consolidate across 8 key areas over the next five-year period. Key action points 2 & 8 relate specifically to this section.

2

Information & resources

Continual development of multi-media resources and information.
8

Targeted research

Targeted call for research (NHMRC/MRFF) for Neuroendocrine Tumours.

Senate Recommendations: 19, 20, 21 & 27

In 2024 a Senate Recommendation was released in response to the inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer’. This inquiry sought to address the significant barriers faced by patients in obtaining timely and effective cancer care.

Senate Recommendations: 1, 18, 19, 22, 29 & 30

In 2024 a Senate Recommendation was released in response to the inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer’. This inquiry sought to address the significant barriers faced by patients in obtaining timely and effective cancer care.

Senate Recommendations: 18 & 19

In 2024 a Senate Recommendation was released in response to the inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer’. This inquiry sought to address the significant barriers faced by patients in obtaining timely and effective cancer care.

Senate Recommendations: 7, 8, 16, 17, 34, 35, 36 & 38

In 2024 a Senate Recommendation was released in response to the inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer’. This inquiry sought to address the significant barriers faced by patients in obtaining timely and effective cancer care.

Senate Recommendations: 3, 4, 5 & 12

In 2024 a Senate Recommendation was released in response to the inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer’. This inquiry sought to address the significant barriers faced by patients in obtaining timely and effective cancer care.

Senate Recommendations: 18 & 19

In 2024 a Senate Recommendation was released in response to the inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer’. This inquiry sought to address the significant barriers faced by patients in obtaining timely and effective cancer care.

National Action Plan: Key Action 3

NECA’s National Action Plan, plans to establish and consolidate across 8 key areas over the next five-year period. Key action point 3 relates specifically to this section.

3

Education of healthcare professionals (HCPs)

Enhanced education for healthcare professionals.

National Action Plan: Key Action 4 & 5

NECA’s National Action Plan, plans to establish and consolidate across 8 key areas over the next five-year period. Key action points 4 & 5 relate specifically to this section.

4

National awareness campaign

A national NET awareness campaign.
5

Optimal Care Pathway

Development and implementation of a National NET Optimal Care Pathway.

National Action Plan: Key Action 6 & 8

NECA’s National Action Plan, plans to establish and consolidate across 8 key areas over the next five-year period. Key action points 6 & 8 relate specifically to this section.

6

Data Registry (PLANET)

Data Registry (PLANET).
8

Targeted research

Targeted call for research (NHMRC/MRFF) for Neuroendocrine Tumours.

National Action Plan: Key Action 1 & 2

NECA’s National Action Plan, plans to establish and consolidate across 8 key areas over the next five-year period. Key action points 1 & 2 relate specifically to this section.

1

NET specialist telehealth nurses

Support for specialist NET telehealth nurses and oncology social workers.
2

Information & resources

Continual development of multi-media resources and information.